Elixirr Shares Tumble Over 10% as In-Line Guidance Overshadows H1 Growth

Shares of Elixirr International (ELIX) plunged more than 10% on Thursday after the consulting firm's latest earnings report, where strong first-half growth was tempered by a full-year outlook that failed to impress the market.

Strong Results Meet Muted Reception

In its unaudited interim results for the six months ended June 30, 2026, Elixirr reported a 25% increase in revenue to £89.0 million. The company highlighted significant growth in its artificial intelligence services, with AI-related revenue surging 185% to £8.1 million.

Other key financial metrics also showed robust growth, according to the release:

• Adjusted EBITDA rose 29% to £27.6 million.
• The adjusted EBITDA margin expanded to 31.0% from 30.0% a year earlier.
• Organic revenue growth at constant currency was 5%.
• Adjusted diluted earnings per share (EPS) increased by 18%.

Guidance and Market Context

Ad

Despite the strong first-half performance, Elixirr stated it expects full-year 2026 revenue and adjusted EBITDA to be "broadly in line with company-compiled market expectations." This guidance, suggesting results will meet but not necessarily beat forecasts, appears to be the primary driver of the negative market reaction for the growth-oriented stock.

The sell-off was exacerbated by the stock's existing technical weakness. According to Investing.com, shares had underperformed the FTSE All-Share index by more than 12% in the six months leading up to the report and were trading well below their 200-day moving average.

Stock Hits 52-Week Low

The company-specific news sent Elixirr's stock down 10.4% to 557.6 pence. During the session, shares touched an intraday low of 532.89p, establishing a new 52-week trough. The day's sharp decline adds to a longer-term downtrend, with the stock now significantly below its 52-week high of 898p.